FDA Approves New Libido-Boosting Drug for Premenopausal Women
Bremelanotide becomes the second FDA-approved drug for hypoactive sexual desire disorder in premenopausal women. It is self-injected at least 45 minutes before sexual activity. News Alerts …read more